Abstract
At present, radiopharmaceuticals are being utilized primarily for the detection, sizing, and localization of acute myocardial infarction. Perhaps a more detailed understanding of their mechanisms of accumulation will permit in-depth study of the pathophysiology of the disease states and mechanisms of action of pharmacologic agents.